Q1 2020 13F Holders as of 31 Mar 2020
-
Type / Class
-
Equity / COM
-
Number of holders
-
89
-
Total 13F shares, excl. options
-
12,392,632
-
Shares change
-
+365,107
-
Total reported value, excl. options
-
$608,333,577
-
Value change
-
+$13,343,069
-
Put/Call ratio
-
74%
-
Number of buys
-
40
-
Number of sells
-
-54
-
Price
-
$48.99
Significant Holders of EIDOS THERAPEUTICS INC - COM (EIDX) as of Q1 2020
120 filings reported holding EIDX - EIDOS THERAPEUTICS INC - COM as of Q1 2020.
EIDOS THERAPEUTICS INC - COM (EIDX) has 89 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 12,392,632 shares
.
Largest 10 shareholders include RA CAPITAL MANAGEMENT, L.P. (2,162,671 shares), BlackRock Inc. (1,417,421 shares), Aisling Capital Management LP (1,123,630 shares), Cormorant Asset Management, LP (1,100,000 shares), Redmile Group, LLC (689,478 shares), PERCEPTIVE ADVISORS LLC (686,922 shares), VANGUARD GROUP INC (443,823 shares), FMR LLC (402,747 shares), GILDER GAGNON HOWE & CO LLC (358,034 shares), and Artisan Partners Limited Partnership (320,173 shares).
This table shows the top 89 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.